Genetics of sarcoidosis

Radjenovic-Petkovic, Tatjana; Pejčić, Tatjana; Ristic, Lidija; Nastasijevic-Borovac, Desa; Radović, M; Djordjević, Snežana

doi:10.2298/mpns13s1007r

Cited by 2 publications

(1 citation statement)

References 24 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, CEA is considered as a tumor marker in clinical findings. 18,19) In medicine, the CEA test contributes to the early and clearly identification of etiologies so that appropriate and effective preventive and curative measures can be taken timely.…”

Section: Introductionmentioning

confidence: 99%

Characterization of Gd2O3:Eu3+ Nanocomplexes Conjugate with IgG for the Identification of CEA Tumor Cells

Lien

Diep

et al. 2020

Mater. Trans.

View full text Add to dashboard Cite

In this paper, the Gd 2 O 3 :Eu 3+ nanospheres with the ratio Eu 3+ /Gd 3+ of 6% mol were successfully synthesized by a multi-step chemical method with the mean nanoparticles size of about 200 to 220 nm and a low standard deviation. The morphology, structure and optical behavior of as-synthesized and annealed Gd 2 O 3 :6%Eu 3+ samples were investigated by field-emission scanning electron microscopy (FESEM), X-ray diffractions (XRD), and photoluminescence spectroscope (PL) The luminescence lifetime of samples was also investigated and discussed. The biomedical nanocomplexes of Gd 2 O 3 :6%Eu 3+ with IgG were fabricated by glutaraldehyde linking after covering nanospheres with amino Silica. The luminescent nanocomplexes Gd 2 O 3 :6%Eu 3+ @Silica-NH 2 -IgG with different concentrations have been incubated with CEA tumor cells to investigate and evaluate the detection capacity by using a fluorescence optical microscopy for the early detection and treatment of cancer.

show abstract

Section: Introductionmentioning

confidence: 99%

Characterization of Gd2O3:Eu3+ Nanocomplexes Conjugate with IgG for the Identification of CEA Tumor Cells

Lien

Diep

et al. 2020

Mater. Trans.

View full text Add to dashboard Cite

show abstract

Genetic factors in the development and course of pulmonary diseases

Pešut¹,

Nagorni-Obradović²,

Jovanović³

et al. 2014

Medicinska istraživanja

View full text Add to dashboard Cite

The year 2013 denoted the 50th anniversary of the discovery of a1-antitrypsin deficiency. Apart from genetic changes in cystic fibrosis, discovered in 1989, the condition was the only recognized genetic disturbance in pulmonary diseases for years. In the meantime, many studies have been undertaken, especially in the diseases of unknown causes such as sarcoidosis, but also in those of well-known infectious cause like tuberculosis. Genetic studies in tuberculosis were especially COM-plex and directed both towards host susceptibility and genetics of Mycobacterium tuberculosis with special reference to the mechanisms of drug resistance development. Apart from animal studies at the beginning of the second half of the 20th century, twins and major histocompatibility system studies, population-genetic and pedigree analysis were performed, then, biomarkers such as ABO system blood types analysis and many others. Availability of molecular techniques allowed great step forward and brought new knowledge on the genetics of pulmonary diseases, including epigenetics. The purpose of the review is to present new findings and highlight importance of current opinion on genetic factors influence in the development, course and prognosis of the most prevalent chronic non-infectious and rare pulmonary diseases.

show abstract

Genetics of sarcoidosis

Cited by 2 publications

References 24 publications

Characterization of Gd<sub>2</sub>O<sub>3</sub>:Eu<sup>3+</sup> Nanocomplexes Conjugate with IgG for the Identification of CEA Tumor Cells

Characterization of Gd<sub>2</sub>O<sub>3</sub>:Eu<sup>3+</sup> Nanocomplexes Conjugate with IgG for the Identification of CEA Tumor Cells

Genetic factors in the development and course of pulmonary diseases

Contact Info

Product

Resources

About